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INTRODUCTION
Primary sclerosing cholangitis (PSC) is a chronic chole-
static syndrome with autoimmune features and is associated
with other immunological diseases such as autoimmune
pancreatitis and inflammatory bowel disease. In addition to
primary biliary cirrhosis, PSC is one of the most common
chronic cholestatic liver diseases.1
The diagnosis of PSC is a challenge because patients are
asymptomatic or display unspecific symptoms. Patients
experience fatigue, pruritus, and jaundice. In addition,
symptom onset is not associated with age. The diagnosis of
PSC is typically achieved after a complication such as
cholangitis or hepatic dysfunction occurs. Patients may
experience periods of remission. Laboratory tests show
cholestatic profiles with high levels of alkaline phosphatases
(APs), gamma-glutamyltransferases (GGTs) and, occasion-
ally, greater bilirubin levels. Definitive diagnosis is achieved
using imagingmethods to assist in the differential diagnosis.2
Endoscopic retrograde cholangiography (ERC) has been
considered the gold-standard diagnostic method for PSC.1
However, ERC has its inherent risks such as acute
pancreatitis, cholangitis, and duodenum perforation.3
Moreover, in a patient with biliary chronic disease, the loss
of the Oddi sphincter barrier may lead to acute complica-
tions and chronic problems such as recurrent cholangitis,
liver abscesses, and reduced liver function.4
Magnetic resonance imaging (MRI) is an attractive option
for PSC diagnosis. Many studies have reported that MRI has
similar sensitivity to ERC for PSC and has the remarkable
advantages of being less invasive and less likely to cause
complications.5
In this case report, we present two patients with PSC who
had serious complications after ERC with recurrent cholan-
gitis and are on the waiting list for a liver transplant.
CASE 1: A 51-year-old male patient with a previous
diagnosis of inflammatory bowel disease (IBD) and com-
plaints of chronic fatigue and pruritus was referred to our
hospital. Liver function tests showed normal transaminase
levels and a two-fold increase in the alkaline phosphatase and
gamma-glutamyl transpeptidase levels. A cholangio-NMR
(c-NMR) study showed a pattern of stenosis and dilation that
suggested a diagnosis of primary sclerosing cholangitis (PSC)
(Figure 1). The patient underwent ERCP with papillotomy,
which confirmed this diagnosis. After three days, the patient
presented with a fever, leukocytosis, and chills. He developed
multiple intra-hepatic abscesses. Acute cholangitis was
diagnosed and successfully treated with long-term IV
antibiotics.
After three years, the patient experienced three more
episodes of cholangitis, which were treated with IV
antibiotics. He is currently on daily prophylactic treatment
with ciprofloxacin and remains asymptomatic.
CASE 2: A 39-year-old woman started having diarrhea,
hepatomegaly, jaundice, and elevated canalicular enzymes
seven years ago. An ERCP with papillotomy was per-
formed, and the findings strongly supported the diagnosis
of PSC (Figure 2). Since then, the patient has experienced at
least four major attacks of acute cholangitis that necessitated
inpatient treatment. She is currently receiving prophylactic
ciprofloxacin daily and is asymptomatic. However, she
developed hepatic cirrhosis with portal hypertension. Three
months ago, she experienced upper gastrointestinal bleed-
ing due to esophageal varices. Liver transplantation has
been indicated, and her current MELD score is 17.
DISCUSSION
The etiology of PSC remains elusive. PSC is related to
other autoimmune diseases, such as IBD and autoimmune
pancreatitis (AP). Genetic studies have demonstrated the
expression of the haplotypes HLA A1-B8-DR3, DR-6, and
DR-2 in some cases of PSC. HLA DR-4 expression is related
to protective effects that are not specific for PSC. The lack of
specificity of these markers remains a challenge in PSC
diagnosis.6
PSC affects more men than women (251). Early clinical
findings are nonspecific. Fatigue, anorexia, and arthralgia
are common symptoms. Jaundice and pruritus are not rare
and are troublesome for the patients.2
Laboratory tests have shown a typical cholestatic profile
with elevated alkaline phosphatase and gamma-glutamyl
transpeptidase levels. Occasionally, slight elevations of
transaminases and bilirubin have been noted. Several
auto-antibody studies have indicated elevated p-ANCA
and anti-nuclear antibodies. However, elevated auto-anti-
bodies are unspecific for PCS. 2,6
Imaging studies are fundamental to the investigation of
any cholestatic disease. The intra- and extra-hepatic biliary
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tree must be thoroughly examined to achieve a differential
diagnosis.1,2,5 In the past, ERCP and percutaneous cholan-
giography have been widely used. ERCP is considered the
gold-standard diagnostic technique for PSC because the
documentation of detailed biliary anatomy that is achieved
with this method is informative. However, ERCP is
associated with complications, including biliary contamina-
tion, cholangitis and pancreatitis.7 New conservative meth-
ods to assess biliary anatomy such as endoscopic ultrasound
(EUS) and cholangio-NMR jeopardize the former pivotal
role of ERCP as the gold-standard technique for the
diagnosis of PSC. Ciorcilan et al. have analyzed the ERCP-
associated complications in patients with cholestatic dis-
eases and have concluded that this method is indicated only
when diagnosis is not possible with EUS or cholangio-NMR
or in patients that require therapeutic intervention.8
Some studies have shown that ERCP may be dangerous
for patients with PSC.9,10 In patients with PSC, liver function
may be impaired after ERCP. Beuers et al. have demon-
strated that cholestasis worsened after ERCP in 53% of
patients with PSC. A bilirubin level that exceeds 1.0 mg/dl
in elderly patients is a risk factor for complications.4
In recent years, cholangio-NMR has undergone a sig-
nificant technical evolution and is a preferred tool to
investigate cholestatic disease. Vitellas et al. have compared
the efficacies of ERCP and cholangio-NMR in the diagnosis
of PSC and concluded that c-NMR defines peripheral biliary
lesions more effectively than ERCP.11 Textor et al. have
concluded that the sensitivity and specificity of c-NMR are
similar to those of ERCP in the diagnosis of PSC and has
fewer complications than ERCP.12
Talwalkar et al. have performed a prospective analysis of
cost-effectiveness and concluded that c-NMR is more
valuable than ERCP as a diagnostic procedure for chole-
static diseases.13 However, ERCP remains a valuable
therapeutic method to manipulate the biliary tree (removal
of sludge and stones and the dilation of the duct).
The cases described in the current report emphasize a rare
but potentially dangerous complication following ERCP in
patients with PSC: acute and recurrent cholangitis (RC).
Nevertheless, there are other similar clinical complications.
Analysis of liver transplantation explants showed that
bacteriobilia is more frequent in patients with PSC than in
patients with PBC.14 Moreover, ERCP increases colonization
by pathogenic flora, which may originate from the endo-
scope itself.15 Furthermore, when performing ERCP in
patients with cholestatic disease, a wide papillotomy may
be necessary for complete contrast wash-out of the biliary
tree. Afterward, duodenal-biliary reflux may occur, leading
to chronic biliary contamination.16,17
These data support the idea that chronic cholangitis is
similar to the recurrent events of acute cholangitis and may
lead to the deterioration of global liver function in patients
with cholestatic diseases. Therefore, the contamination of a
diseased biliary tree should be avoided whenever possible.
ERCP with papillotomy may complicate cholestatic liver
disease. Because other non-invasive tests such as cholangio-
NMR are currently widely available, we believe that ERCP
has a limited role in the diagnosis of PSC and should be
indicated only for therapeutic purposes in patients with PSC.
AUTHOR CONTRIBUTIONS
Andraus W wrote the manuscript. Haddad L was responsible for the
English revisions and writing. Nacif LS and Silva FD were responsible for
the data collection. Blasbalg R was responsible for the radiology revisions.
D’Albuquerque LAC was responsible for the manuscript revisions.
REFERENCES
1. Angulo P, Lindor KD. Primary sclerosing cholangitis. Hepatology.
1999;30:325-32, doi: 10.1002/hep.510300101.
2. Schrumpf E, Boberg KM. Primary sclerosing cholangitis: challenges of a
new millenium. Dig Liver Dis. 2000;32:753-5, doi: 10.1016/S1590-
8658(00)80350-3.
Figure 2 - Endoscopic retrograde cholangiopancreatography
showing intra- and extrahepatic bile-duct strictures and dilations.
Figure 1 - Cholangio-NMR showing intrahepatic bile-duct
strictures that are consistent with a diagnosis of PSC.
An alternative approach for diagnosing PSC
Andraus W et al.
CLINICS 2011;66(11):1987-1989
1988
3. Moff SL, Kamel IR, Eustace J, Lawler LP, Kantsevoy S, Kalloo AN, et al.
Diagnosis of primary sclerosing cholangitis: a blinded comparative study
using magnetic resonance cholangiography and endoscopic retrograde
cholangiography. Gastrointest Endosc. 2006;64:219-23, doi: 10.1016/j.gie.
2005.12.034.
4. Beuers U, Spengler U, Sackmann M, Paumgartner G, Sauerbruch T.
Deterioration of cholestasis after endoscopic retrograde cholangiography
in advanced primary sclerosing cholangitis. J Hepatol. 1992;15:140-3, doi:
10.1016/0168-8278(92)90026-L.
5. Angulo P, Pearce DH, Johnson CD, Henry JJ, LaRusso NF, Petersen BT,
et al. Magnetic resonance cholangiography in patients with biliary
disease: its role in primary sclerosing cholangitis. J Hepatol. 2000;33:520-
7, doi: 10.1034/j.1600-0641.2000.033004520.x.
6. Maggs JR, Chapman RW. Sclerosing cholangitis. Curr Opin
Gastroenterol. 2007;23:310-6, doi: 10.1097/MOG.0b013e32805867e6.
7. Ang TL, Fock KM, Ng TM, Teo EK, Chua TS, Tan JY. Clinical profile of
primary sclerosing cholangitis in Singapore. J Gastroenterol Hepatol.
2002;17:908-13, doi: 10.1046/j.1440-1746.2002.02835.x.
8. Ciocirlan M, Ponchon T. Diagnostic endoscopic retrograde cholangiopan-
creatography. Endoscopy. 2004;36:137-46, doi: 10.1055/s-2004-814181.
9. Enns R, Eloubeidi MA, Mergener K, Jowell PS, Branch MS, Baillie J.
Predictors of successful clinical and laboratory outcomes in patients with
primary sclerosing cholangitis undergoing endoscopic retrograde cho-
langiopancreatography. Can J Gastroenterol. 2003;17:243-8.
10. Christensen M, Hendel HW, Rasmussen V, Hojgaard L, Schulze S,
Rosenberg J. Endoscopic retrograde cholangiopancreatography causes
reduced myocardial blood flow. Endoscopy. 2002;34:797-800, doi: 10.
1055/s-2002-34270.
11. Vitellas KM, El-Dieb A, Vaswani KK, Bennett WF, Tzalonikou M,
Mabee C, et al. MR cholangiopancreatography in patients with primary
sclerosing cholangitis: interobserver variability and comparison with
endoscopic retrograde cholangiopancreatography. AJR Am J Roentgenol.
2002;179:399-407.
12. Textor HJ, Flacke S, Pauleit D, Keller E, Neubrand M, Terjung B, et al.
Three-dimensional magnetic resonance cholangiopancreatography with
respiratory triggering in the diagnosis of primary sclerosing cholangitis:
comparison with endoscopic retrograde cholangiography. Endoscopy.
2002;34:984-90, doi: 10.1055/s-2002-35830.
13. Talwalkar JA, Angulo P, Johnson CD, Petersen BT, Lindor KD. Cost-
minimization analysis of MRC versus ERCP for the diagnosis of primary
sclerosing cholangitis. Hepatology. 2004;40:39-45, doi: 10.1002/hep.20287.
14. Rosch T, Triptrap A, Born P, Ott R, Weigert N, Frimberger E, et al.
Bacteriobilia in percutaneous transhepatic biliary drainage: occurrence
over time and clinical sequelae. A prospective observational study.
Scand J Gastroenterol. 2003;38:1162-8, doi: 10.1080/00365520310003549.
15. Pohl J, Ring A, Stremmel W, Stiehl A. The role of dominant stenoses in
bacterial infections of bile ducts in primary sclerosing cholangitis.
Eur J Gastroenterol Hepatol. 2006;18:69-74, doi: 10.1097/00042737-
200601000-00012.
16. Bordas JM, Elizalde I, Llach J, Mondelo F, Bataller R, Teres J. Biliary
reflux due to sphincter of Oddi ablation: a new pathogenetic explanation
for long-term major biliary symptoms after endoscopic-sphincterotomy.
Endoscopy. 1996;28:642, doi: 10.1055/s-2007-1005568.
17. Mandryka Y, Klimczak J, Duszewski M, Kondras M, Modzelewski B.
[Bile duct infections as a late complication after endoscopic sphincter-
otomy]. Pol Merkur Lekarski. 2006;21:525-7.
CLINICS 2011;66(11):1987-1989 An alternative approach for diagnosing PSC
Andraus W et al.
1989
